不同亚型的多囊卵巢综合征患者临床及实验室指标特征的研究

doi:10.3969/j.issn.1006-7795.2015.04.010

首都医科大学学报 ›› 2015, Vol. 36 ›› Issue (4): 567-572.doi: 10.3969/j.issn.1006-7795.2015.04.010

• 更年期与妇科生殖内分泌 • 上一篇下一篇

不同亚型的多囊卵巢综合征患者临床及实验室指标特征的研究

赵越¹, 阮祥燕^1,2, 崔亚美¹, 李扬璐¹, 武红琴¹, 杜娟¹, 张颖¹, 田玄玄¹, Diethelm Wallwiener², Alfred O. Meuck^1,2

1. 首都医科大学附属北京妇产医院内分泌科, 北京 100026;
2. 德国图宾根大学妇产医院内分泌与绝经研究中心, 图宾根 D-72076, 德国

收稿日期:2015-05-22 出版日期:2015-08-21 发布日期:2015-07-17
通讯作者: 阮祥燕 E-mail:ruanxiangyan@163.con
基金资助:
国家外国专家局2015年度北京市引进国外技术、管理人才项目(GDJ20151100013),北京市卫生系统高层次卫生技术人才(学科带头人)(2014-2-016),首都医科大学附属北京妇产医院,北京妇幼保健院学科带头人项目(2013-1)。

Clinical and endocrine characteristics among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria

Zhao Yue¹, Ruan Xiangyan^1,2, Cui Yamei¹, Li Yanglu¹, Wu Hongqin¹, Du Juan¹, Zhang Ying¹, Tian Xuanxuan¹, Diethelm Wallwiener², Alfred O. Meuck^1,2

1. Department of Endocrinology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100026, China;
2. Department of Endocrinology, University Women's Hospital of Tubingen, Tubingen D-72076, Germany

Received:2015-05-22 Online:2015-08-21 Published:2015-07-17
Supported by:
This study was supported by Foreign Technical and Administrative Talent Introduction Project in 2015, State Administration of Foreign Experts Affairs, the P. R. of China(GDJ20151100013); Beijing Municipality Health Technology High-level Talent(2014-2-016); Project of Discipline Leader, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing Maternal and Child Health Health Care Hospital(2013-1).

摘要/Abstract

摘要：

目的基于鹿特丹标准,依据美国国立卫生院(National Institutes of Health,NIH)最新指南推荐,探讨不同亚型多囊卵巢综合征(polycystic ovary syndrome,PCOS)患者临床、内分泌代谢等相关指标特征,以指导临床治疗。方法募集2014年12月至2015年5月在首都医科大学附属北京妇产医院内分泌科就诊的PCOS患者647例,测定人体学指标、性激素及血脂、血糖、胰岛素及阴道B超等,依据NIH指南推荐将其四型分为4组:A 组409例〔O+HA+P:无排卵或稀发排卵(oligo-ovulation,O),雄激素水平升高的临床和(或)生化表现(hyperandrogeoism,HA),卵巢多囊样改变(polycystic ovary,P)〕;B 组58例(O+HA);C组101例(HA+P);D组79例(O+P),另选同期就诊的基础体温双相的输卵管因素不孕症患者60例为对照组,分别评估临床及激素代谢指标。结果 647例患者,4个亚型的患病率分别为: A组63.2%,B组9% ,C组15.6%,D组12.9%,647例患者中有高雄表现或血雄激素浓度高的发生率为87.8%。A组与B组:高雄血症、腰围、胰岛素抵抗及三酰甘油均明显增高,但 A组最重,B组次之。C组与A、B两组相比,临床和内分泌代谢特征温和,但与对照组相比,黄体生成素(luteinizing hormone,LH)、黄体生成素/卵泡刺激素(LH/follicle stimulating hormone,FSH)均明显增高(P<0.05)。D组与对照组间体质量指数(body mass index,BMI)、腰围、臀围、Ferryman-Gallwey评分结果相似。部分特殊化指标质量浓度各组间差异均无统计学意义(P>0.05)。结论 1) 基于鹿特丹诊断标准的PCOS分型方法可反映疾病的基本特征。2) 高雄激素血症和/或多毛评分是区分PCOS不同亚型最主要的依据,可能是代谢障碍严重程度不同的结果。与标准组(Ⅰ型和Ⅱ型相比),正常排卵组和非高雄组可代表PCOS相对温和的表型。而非高雄组PCOS可能有不同的致病途径。因此对于不同分型PCOS患者的治疗也应该个体化。

关键词: 多囊卵巢综合征, 胰岛素抵抗, 分型, 鹿特丹标准, 总睾酮

Abstract:

Objective To analyze the relative prevalence and the clinical and endocrine characteristics of each phenotype expressions of polycystic ovary syndrome(PCOS) according to the National Institutes of Health(NIH) and Rotterdan Consensus criteria definitions for PCOS. Methods Clinical, endocrine and metabolic data from 647 women with PCOS diagnosed according to Rotterdam criteria and NIH recommendations between Dec. 2014 and May 2015 were collected and divided into four different phenotypes. Results The severe PCOS phenotype defined as having oligo-ovulation(OO), hyperandrogenism(HA), and polycystic ovary(PCO), i.e., Group A, was the most common phenotype seen in 63.2% of the patients. Group B, defined as having OO and HA, was seen in 9% of the phenotype. Group C, defined as having HA and PCO, was seen in 15.6% and Group D, defined as having OO and PCO, was seen in 12.9%. The rate of clinical high androgen manifestation and hyperandrogenism was 87.8%, but hyperandrogenism, insulin resistance(IR) and triglyceride(TG) were significantly higher in Group A, followed by group B. Group C presented relatively milder clinical and endocrine alterations than group A and B, but had a higher luteinizing hormone/follicle-stimulating hormone(LH/FSH) than controls(P<0.05). Compared with controls, group D had similar body mass index(BMI), waist and hip circumferences, and Ferryman-Gallwey scores. Several biochemical indicator were similar across all PCOS phenotypes(P>0.05). Conclusion 1) The classification according to the revised 2003 consensus on diagnosis reflects the basic characteristics of PCOS. 2) Androgen levels are the major distinguishing endocrine feature differentiating phenotypic expressions of PCOS. Ovulatory PCOS and normoandrogenic phenotype represent the mild forms of classic PCOS, but the latter may have a different pathogenic pathway. So the choice of treatment should be individualized.

Key words: polycystic ovary syndrome, insulin resistance, phenotype, Rotterdam criteria, testosterone

中图分类号:

R711.75

赵越, 阮祥燕, 崔亚美, 李扬璐, 武红琴, 杜娟, 张颖, 田玄玄, Diethelm Wallwiener, Alfred O. Meuck. 不同亚型的多囊卵巢综合征患者临床及实验室指标特征的研究[J]. 首都医科大学学报, 2015, 36(4): 567-572.

Zhao Yue, Ruan Xiangyan, Cui Yamei, Li Yanglu, Wu Hongqin, Du Juan, Zhang Ying, Tian Xuanxuan, Diethelm Wallwiener, Alfred O. Meuck. Clinical and endocrine characteristics among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria[J]. Journal of Capital Medical University, 2015, 36(4): 567-572.

参考文献

[1] Zhao Y, Du B, Jiang X, et al. Effects of combining low-dose aspirin with a Chinese patent medicine on follicular blood flow and pregnancy outcome[J]. Mol Med Rep, 2014,10(5):2372-2376.
[2] Fauser B C, Tarlatzis B C, Rebar R W, et al. Consensus on women's health aspects of polycystic ovary syndrome(PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group[J]. Fertil Steril., 2012,97(1):28-38.
[3] The Rotterdam ESHER/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus of diagnostic criteria and long-term health risks related to polycystic ovary syndrome(PCOS). Hum Reprod, 2004,19(1):41-47.
[4] Salameh W A, Redor-Goldman M M, Clarke N J, et al. Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria[J]. Fertil Steril, 2014,101(4):1135-1141.
[5] 田玄玄,阮祥燕,王娟,等.473例多囊卵巢综合征相关因素调查分析[J].首都医科大学学报,2014,35(8):414-418.
[6] 陈春明,孔灵芝.中国成人超重和肥胖症预防控制指南[M].北京:人民卫生出版社,2006:1 -35.
[7] Wang T, Guo Y, Song and W Huang.'Association dipocyte factor level and insulin resistance in polycystic ovary syndrome'[J]. Gynecological Endocrinology, 2011,27(11):p931-p934.
[8] Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome[J]. Fertil Steril, 2008,89(3):505-522.
[9] Dewailly D, Catteau-Jonard S, Reyss AC, et al. Oligoanovulation with polycystic ovaries but not overt hyperandrogenism[J]. J Clin Endocrinol Metab, 2006,91(10):3922-3927.
[10] Welt C K, Gudmundsson J A, Arsson G, et al. Characterizin discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic feature[J]. J Clin Endocrinol Metab, 2006, 91:4842-4848.
[11] Guastella E, Longo R A, Carmina E. Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes[J]. Fertil and Steril, 2010,94(6):2197-2201.
[12] Li R J, Qiu S D, Wang H X, et al. Androgen receptor: a new player associated with apoptosis and proliferation of pancreatic beta cell in type 1 diabetes mellitus[J]. Apoptosis, 2008,13(8):957-971.

[1]	刘春涛, 苏珈仪, 旦增卓嘎, 伊比然恨, 卓玛, 张澍田. 西藏自治区藏族人群幽门螺杆菌毒力菌株分型与慢性胃炎及消化性溃疡的相关性研究[J]. 首都医科大学学报, 2022, 43(3): 463-468.
[2]	李健, 白文佩, 江波, 白栎然, 吴凤云. 生酮饮食对超重/肥胖多囊卵巢综合征女性月经及生育力的影响[J]. 首都医科大学学报, 2021, 42(6): 1021-1025.
[3]	王莉, 张国军. 血清神经元特异性烯醇化酶与外伤性脑损伤患者及临床特征的关系[J]. 首都医科大学学报, 2021, 42(5): 715-720.
[4]	王虎生, 阮祥燕, 程姣姣, Alfred O. Mueck. 肥胖型多囊卵巢综合征的氧化应激与脂代谢关系的研究[J]. 首都医科大学学报, 2021, 42(4): 540-546.
[5]	杨瑜, 阮祥燕, 鞠蕊, 许新, 谷牧青, 程姣姣. 屈螺酮炔雌醇Ⅱ对多囊卵巢综合征患者血清抗苗勒管激素的影响[J]. 首都医科大学学报, 2021, 42(4): 547-552.
[6]	刘真, 殷冬梅, 战思恩, 阮祥燕. 黄连素改善多囊卵巢综合征患者代谢异常的系统评价[J]. 首都医科大学学报, 2021, 42(4): 588-595.
[7]	王景尚, 尹晓丹, 何军琴, 武颖, 张莹, 李宪锐. 来曲唑联合高糖高脂饮食构建多囊卵巢综合征伴胰岛素抵抗大鼠模型研究[J]. 首都医科大学学报, 2021, 42(3): 436-442.
[8]	张黎锐, 郑薇, 刘程, 梁馨, 张莉, 田志红, 李光辉. 多囊卵巢综合征孕妇妊娠期增重模式与母儿结局的关系[J]. 首都医科大学学报, 2021, 42(2): 169-176.
[9]	杨祎林, 罗莎, 史婷婷, 信中. ^99mTC-二乙烯三胺五乙酸眼眶SPECT/CT在甲状腺相关性眼病分型及活动度评价中的作用[J]. 首都医科大学学报, 2021, 42(2): 280-285.
[10]	姚春勇, 李杨帆, 贾原菊. 66例新型冠状病毒肺炎患者临床特点及胸部电子计算机断层扫描影像表现分析[J]. 首都医科大学学报, 2020, 41(6): 997-1001.
[11]	闵敏, 阮祥燕, 王虎生, 程姣姣, 罗穗豫, 许仲婷, 李萌, Alfred O. Mueck. 奥利司他综合干预对超重或肥胖型多囊卵巢综合征患者代谢综合征及其组分的影响[J]. 首都医科大学学报, 2020, 41(4): 514-519.
[12]	王宾红, 阮祥燕, 鞠蕊, 豆竹丽, 秦爽, 张露平, 许新, 杨瑜, Alfred O. Mueck. 综合干预治疗对多囊卵巢综合征患者雄激素浓度的影响[J]. 首都医科大学学报, 2020, 41(4): 520-524.
[13]	豆竹丽, 阮祥燕, 鞠蕊, 王宾红, 秦爽, 许新, 杨瑜, 张露平. 综合干预后多囊卵巢综合征不孕患者应用来曲唑促排卵的临床效果[J]. 首都医科大学学报, 2020, 41(4): 525-529.
[14]	秦爽, 阮祥燕, 王宾红, 鞠蕊, 张露平, 豆竹丽, 程姣姣, 金婧. 多囊卵巢综合征患者促排卵周期中成熟卵泡性激素浓度对妊娠的影响[J]. 首都医科大学学报, 2020, 41(4): 530-535.
[15]	董方, 陈东, 商建峰, 方微, 滕飞, 张睿祺. 门诊消化系统疾病患者幽门螺杆菌感染状况分析[J]. 首都医科大学学报, 2020, 41(3): 372-375.

不同亚型的多囊卵巢综合征患者临床及实验室指标特征的研究

Clinical and endocrine characteristics among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价